Pesquisas alternativas:
development type » development types (Expandir a Pesquisa), development time (Expandir a Pesquisa), development three (Expandir a Pesquisa)
doses developing » does developing (Expandir a Pesquisa), costs developing (Expandir a Pesquisa), masses developing (Expandir a Pesquisa)
cases developing » case developing (Expandir a Pesquisa), masses developing (Expandir a Pesquisa), costs developing (Expandir a Pesquisa)
de development » de developpment (Expandir a Pesquisa), de developpement (Expandir a Pesquisa), line development (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug deal (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
development type » development types (Expandir a Pesquisa), development time (Expandir a Pesquisa), development three (Expandir a Pesquisa)
doses developing » does developing (Expandir a Pesquisa), costs developing (Expandir a Pesquisa), masses developing (Expandir a Pesquisa)
cases developing » case developing (Expandir a Pesquisa), masses developing (Expandir a Pesquisa), costs developing (Expandir a Pesquisa)
de development » de developpment (Expandir a Pesquisa), de developpement (Expandir a Pesquisa), line development (Expandir a Pesquisa)
drug de » drug dose (Expandir a Pesquisa), drug deal (Expandir a Pesquisa), drug dna (Expandir a Pesquisa)
1
Por Tácio de Mendonça Lima, Millena Padela da Silva, Luan Donato Silva Luz, Thais Cristina Amorim Estevão Soares, Etielle Silvestre Dantas, Gabriela Felix Teixeira, Rafael Henrique de Souza Costa, Sérgio Henrique Monte Santo Andrade
Publicado em 2022-03-01
Assuntos:
“...Drug dosage calculation...”Publicado em 2022-03-01
Obter o texto integral
Artigo
2
Por Maíra Rocha Machado, Mariana Celano de Souza Amaral, Matheus de Barros, Ana Clara Klink de Melo
Publicado em 2019-06-01
Assuntos:
“...drug trafficking...”Publicado em 2019-06-01
Obter o texto integral
Artigo
3
“... termination of drug development or withdrawal of drugs from the market. Management of such interactions...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
4
“...Renal and cardiovascular complications make type 2 diabetes one of the most morbid conditions...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
5
Por Huang, Fangjin, Ma, Zhaoxuan, Pollan, Sara, Yuan, Xiaopu, Swartwood, Steven, Gertych, Arkadiusz, Rodriguez, Maria, Mallick, Jayati, Bhele, Sanica, Guindi, Maha, Dhall, Deepti, Walts, Ann E, Bose, Shikha, de Peralta Venturina, Mariza, Marchevsky, Alberto M, Luthringer, Daniel J, Feller, Stephan M, Berman, Benjamin, Freeman, Michael R, Alvord, W Gregory, Vande Woude, George, Amin, Mahul B, Knudsen, Beatrice S
Publicado no J Pathol Clin Res (2016)
“... specific antibody selection and should be developed in those cancer types in which they are employed...”Publicado no J Pathol Clin Res (2016)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
6
Por Green, Ezekiel, Obi, Lawrence C., Okoh, Anthony I., Nchabeleng, Maphoshane, Villiers, Babsie E. De, Letsoalo, Tomas, Hoosen, Anwar A., Bessong, Pascal O., Ndip, Roland N.
Publicado em 2013
“...% of TB cases, with 98% of death occur in developing countries. The situation in South Africa merits...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Artigo
7
Por Johnson, Amy J., Lucas, David M., Muthusamy, Natarajan, Smith, Lisa L., Edwards, Ryan B., De Lay, Michael D., Croce, Carlo M., Grever, Michael R., Byrd, John C.
Publicado em 2006
“...Drug development in human chronic lymphocytic leukemia (CLL) has been limited by lack of a suitable...”Publicado em 2006
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
8
“.... Unfortunately, as is the case for other classes of antiretroviral drugs that target later steps in the viral...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
9
“... development of skin lesions, mortality, and latency was related to the dose of ACV-resistant virus used...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
10
“...Background. Drug resistance development in the human immunodeficiency virus (HIV)-infected...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
11
Por Stilianakis, N I, Boucher, C A, De Jong, M D, Van Leeuwen, R, Schuurman, R, De Boer, R J
Publicado em 1997
“... of zidovudine is due to the outgrowth of wild-type virus and the first drug-resistant mutant, whereas...”Publicado em 1997
Obter o texto integral
Obter o texto integral
Artigo
12
Por Van Marck, H., Dierynck, I., Kraus, G., Hallenberger, S., Pattery, T., Muyldermans, G., Geeraert, L., Borozdina, L., Bonesteel, R., Aston, C., Shaw, E., Chen, Q., Martinez, C., Koka, V., Lee, J., Chi, E., de Béthune, M.-P., Hertogs, K.
Publicado em 2009
“... understanding of the molecular basis of resistance development. The novel bioinformatics resistance...”Publicado em 2009
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
13
“... for systemic adenovirus infections rely on a nonhuman adenovirus. We established mouse adenovirus type 1 (MAV-1...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
14
Por Bacci, Marcelo Rodrigues, Cavallari, Marina Romera, de Rozier-Alves, Ross Martin, Alves, Beatriz da Costa Aguiar, Fonseca, Fernando Luiz Affonso
Publicado no Drug Des Devel Ther (2015)
“...Hypertension and diabetes are clinical conditions which contribute to the development of chronic...”Publicado no Drug Des Devel Ther (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
15
Por Sablón-Carrazana, Marquiza, Fernández, Isaac, Bencomo, Alberto, Lara-Martínez, Reyna, Rivera-Marrero, Suchitil, Domínguez, Guadalupe, Pérez-Perera, Rafaela, Jiménez-García, Luis Felipe, Altamirano-Bustamante, Nelly F., Diaz-Delgado, Massiel, Vedrenne, Fernand, Rivillas-Acevedo, Lina, Pasten-Hidalgo, Karina, Segura-Valdez, María de Lourdes, Islas-Andrade, Sergio, Garrido-Magaña, Eulalia, Perera-Pintado, Alejandro, Prats-Capote, Anaís, Rodríguez-Tanty, Chryslaine, Altamirano-Bustamante, Myriam M.
Publicado no PLoS One (2015)
“...The increasing prevalence of conformational diseases, including Alzheimer's disease, type 2...”Publicado no PLoS One (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
16
“.... In this observational study we investigated developmental milestones of fetal behavior during the pregnancy of women...”
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
17
Por Phillips, Gail Lewis
Publicado em c201
“...Cancer drug discovery and development...”Publicado em c201
Obter o texto integral
Livro
18
Por Demonceau, Jenny, Ruppar, Todd, Kristanto, Paulus, Hughes, Dyfrig A., Fargher, Emily, Kardas, Przemyslaw, De Geest, Sabina, Dobbels, Fabienne, Lewek, Pawel, Urquhart, John, Vrijens, Bernard
Publicado em 2013
“... of strategies and components thereof that improve implementation of the prescribed drug dosing regimen...”Publicado em 2013
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo
19
Por Maria Ines Quintana, Sergio Baxter Andreoli, Marcela Poctich Peluffo, Wagner Silva Ribeiro, Marcelo M Feijo, Rodrigo Affonseca Bressan, Evandro S F Coutinho, Jair de Jesus Mari
Publicado em 2015-01-01
“...To estimate the prevalence of one month psychotropic drug use in São Paulo, Brazil, and to assess...”Publicado em 2015-01-01
Obter o texto integral
Artigo
20
Por Quintana, Maria Ines, Andreoli, Sergio Baxter, Peluffo, Marcela Poctich, Ribeiro, Wagner Silva, Feijo, Marcelo M., Bressan, Rodrigo Affonseca, Coutinho, Evandro S. F., Mari, Jair de Jesus
Publicado no PLoS One (2015)
“...OBJECTIVE: To estimate the prevalence of one month psychotropic drug use in São Paulo, Brazil...”Publicado no PLoS One (2015)
Obter o texto integral
Obter o texto integral
Obter o texto integral
Artigo